- Home
- FDMT vs VKI Comparison
FDMT vs VKI Comparison
Compare FDMT & VKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FDMT | VKI |
|---|---|---|
| Founded | 2013 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.9M | 406.3M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | FDMT | VKI |
|---|---|---|
| Price | $9.48 | $9.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $34.13 | N/A |
| AVG Volume (30 Days) | ★ 728.1K | 112.8K |
| Earning Date | 02-27-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.52% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $120,000.00 | N/A |
| Revenue This Year | $21,227.03 | N/A |
| Revenue Next Year | $161.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 605.88 | N/A |
| 52 Week Low | $2.24 | $7.07 |
| 52 Week High | $12.34 | $8.98 |
Technical Indicators
Market Signals| Indicator | FDMT | VKI |
|---|---|---|
| Relative Strength Index (RSI) | 59.94 | 73.06 |
| Support Level | $8.75 | $9.04 |
| Resistance Level | $9.78 | $9.27 |
| Average True Range (ATR) | 0.63 | 0.10 |
| MACD | 0.10 | 0.04 |
| Stochastic Oscillator | 83.00 | 96.00 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About VKI Invesco Advantage Municipal Income Trust II of Beneficial Interest (DE)
Invesco Advantage Municipal Income Trust II is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.